Day: February 17, 2026

VANCOUVER, British Columbia, Feb. 17, 2026 (GLOBE NEWSWIRE) — Skeena Resources Limited (TSX: SKE, NYSE: SKE) (“Skeena Gold & Silver”, “Skeena” or the “Company”) is pleased to share a construction video update for its 100%-owned Eskay Creek Gold-Silver Project (“Eskay” or the “Project”). This six-minute video features members of Skeena’s leadership team, including Executive Chairman Walter Coles, President & CEO Randy Reichert, VP of Operations Kyle Foster, and VP of Project Engineering & Construction Andrew Osterloh. The video provides investors with a firsthand look at construction progress at site and the disciplined efforts of the Management team to deliver the project safely, efficiently, and on schedule. The video is available here, on the company website and social media channels. About Skeena Skeena is a leading...

Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s diseaseIn the RELIEVE UCCD LTE phase 2b study, duvakitug showed robust, durable efficacy for an additional 44 weeks in UC and CD patients who had responded after 14 weeks of induction Duvakitug was well tolerated and safety was consistent with the induction study Findings reinforce the potential of duvakitug which is in ongoing phase 3 programs in UC and CDParis and Parsippany, NJ, February 17, 2026. Positive results from the RELIEVE UCCD long-term extension (LTE) study (clinical study identifier: NCT05668013) of duvakitug, an investigational human monoclonal antibody targeting TL1A, showed durable clinical and endoscopic efficacy maintained over 44 weeks in patients with ulcerative colitis (UC)...

In the RELIEVE UCCD LTE phase 2b study, duvakitug showed robust, durable efficacy for an additional 44 weeks in UC and CD patients who had responded after 14 weeks of induction Duvakitug was well tolerated and safety was consistent with the induction study Findings reinforce the potential of duvakitug which is in ongoing phase 3 programs in UC and CDTeva will hold an investor call and live webcast today, Tuesday, February 17, 2026, at 8:00 a.m. ET to discuss these data. PARSIPPANY, N.J. and PARIS, Feb. 17, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Sanofi announced positive results from the RELIEVE UCCD long-term extension (LTE) study of duvakitug, an investigational human monoclonal antibody targeting TL1A, which showed durable clinical and...

Global Leader in High-Density Data Center Engineering and Liquid Cooling NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (“IREN”) today announced the appointment of John Gross as Chief Innovation Officer, a newly established role responsible for leading engineering standards, thermal architecture, and commissioning across IREN’s next-generation data centers. Mr. Gross is a globally recognized leader in data center engineering, with two decades of industry experience and deep expertise in high-density and liquid-cooled data center design. He serves as Vice Chair of committees within ASHRAE (American Society of Heating, Refrigerating and Air-Conditioning Engineers), which develops global standards for high-density and liquid-cooled data centers. As AI workloads increase in density and thermal intensity, leadership...

Vow ASA (OSE: VOW) will release its report for the fourth quarter 2025 on Wednesday 25 February 2026. The report will be published on https://newsweb.oslobors.no/ and on the company’s web site www.vowasa.com. A live audio webcast will be held the same day at 08:30 CET, hosted by Gunnar Pedersen, CEO, and Cecilie Brænd Hekneby, CFO. The webcast will include a Q&A session, and participants may submit questions in writing at any time during the event. To register and follow the presentation online, please copy and paste the following link into your browser, click Attend and register your email:  https://qcnl.tv/p/WlIPLn2X3L3hwCkzv_bukgFor further information, please contact: Gunnar Pedersen, CEO, Vow ASA Tel: +47 91 63 03 04 Email: gunnar.pedersen@vowasa.comCecilie Brænd Hekneby, CFO, Vow ASA Tel: +47 99 29 38 26 Email: cecilie.hekneby@vowasa.comAbout...

SalMar ASA (“SalMar”), rated BBB+/Negative Outlook by Nordic Credit Rating, has successfully issued a new NOK 750 million senior unsecured green bond with a 10‑year tenor and a coupon of 5.625% (equivalent to a floating rate of 3mN+150bps). An application will be submitted for the bond to be listed on the Oslo Stock Exchange. Settlement is set to 25 February 2026. Danske Bank acted as Sole Manager for the transaction.For further information, please contact: Håkon Husby, Head of Investor Relations Phone: +47 936 30 449 E-mail: hakon.husby@salmar.noThis information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act